Skip to main content
Top
Published in: Clinical Rheumatology 1/2021

01-01-2021 | Systemic Lupus Erythematosus | Original Article

Urinary ferritin creatinine ratio, a potential biomarker for lupus nephritis activity

Authors: Lin Qi, Jingyi Xu, Chunshu Yang, Xiaoyu Hou, Pingting Yang

Published in: Clinical Rheumatology | Issue 1/2021

Login to get access

Abstract

Introduction/objective

Ferritin has gained increasing attention in systemic lupus erythematosus (SLE).This study aimed to investigate the clinical significance of urinary ferritin/creatinine ratio in lupus nephritis (LN).

Method

Samples from 62 SLE patients (35 with LN and 27 without LN) and 62 healthy controls were evaluated. There were nine patients who underwent renal biopsy. The amount of urinary ferritin was measured by enzyme-linked immunosorbent assay (ELISA) and normalized by the amount of urinary creatinine to obtain the urinary ferritin/creatinine ratio (UFCR). The relationships between UFCR and inflammatory markers, laboratory indicators, as well as the activity index (AI), and chronicity index (CI) of KBs were also investigated by correlation analysis.

Results

UFCR level in severe active SLE patients was significantly higher than that in inactive SLE patients (P < 0.01) or healthy controls (P < 0.01). In addition, UFCR level was significantly increased in the patients with LN when compared with those without LN (P < 0.01).Correlation analysis showed that UFCR level is positively correlated with Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) (P < 0.01), 24 h urine protein quantitation, serum creatinine, serum cystatin C, and GFR. The UFCR levels was significantly positively correlated with AI (P < 0.05) but not CI (P = 0.614) of KBs.

Conclusions

UFCR level is a potential biomarker for the kidney injury in LN.
Key Points
• UFCR level is significantly increased in LN patients.
• UFCR level is positively correlated with SLEDAI.
• UFCR level is closely related to kidney injury indicators.
• UFCR level is a potential biomarker for the kidney injury in LN.
Literature
1.
go back to reference Rekvig OP, Van der Vlag J (2014) The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved. SeminImmunopathol 36(3):301–311 Rekvig OP, Van der Vlag J (2014) The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved. SeminImmunopathol 36(3):301–311
2.
go back to reference Wu XY, Yang M, Xie YS et al (2019) Causes of death in hospitalized patients with systemic lupus erythematosus: a 10-year multicenter nationwide Chinese cohort[J]. Clin Rheumatol 38(1):107–115CrossRef Wu XY, Yang M, Xie YS et al (2019) Causes of death in hospitalized patients with systemic lupus erythematosus: a 10-year multicenter nationwide Chinese cohort[J]. Clin Rheumatol 38(1):107–115CrossRef
3.
go back to reference Moore C, Ormseth M (2013) Causes and significance of markedly elevated serum ferritin levels in an academic medical center[J]. J Clin Rheumatol 19(6):324–328CrossRef Moore C, Ormseth M (2013) Causes and significance of markedly elevated serum ferritin levels in an academic medical center[J]. J Clin Rheumatol 19(6):324–328CrossRef
4.
go back to reference Vanarsa K, Ye Y, Han J et al (2012) Inflammation associated anemia and ferritin as disease markers in SLE[J]. Arthritis Res Ther 14(4):R182CrossRef Vanarsa K, Ye Y, Han J et al (2012) Inflammation associated anemia and ferritin as disease markers in SLE[J]. Arthritis Res Ther 14(4):R182CrossRef
5.
go back to reference Verma N, Chakraverty J, Baweja P et al (2017) Extremely high ferritinemia associated with haemophagocytic lymphohistiocytosis (HLH)[J]. Indian J Clin Biochem 32(1):117–120CrossRef Verma N, Chakraverty J, Baweja P et al (2017) Extremely high ferritinemia associated with haemophagocytic lymphohistiocytosis (HLH)[J]. Indian J Clin Biochem 32(1):117–120CrossRef
6.
go back to reference Rosário C, Zandman-Goddard G, Meyron-Holtz EG, D’Cruz DP, Shoenfeld Y (2013) The hyperferritinemic syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome[J]. BMC Med 11:185CrossRef Rosário C, Zandman-Goddard G, Meyron-Holtz EG, D’Cruz DP, Shoenfeld Y (2013) The hyperferritinemic syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome[J]. BMC Med 11:185CrossRef
7.
go back to reference Zandman-Goddard G, Orbach H, Agmon-Levin N et al (2013) Hyperferritinemia is associated with serologic antiphospholipid syndrome in SLE Patients[J]. Clin Rev Allergy Immunol 44(1):23–30CrossRef Zandman-Goddard G, Orbach H, Agmon-Levin N et al (2013) Hyperferritinemia is associated with serologic antiphospholipid syndrome in SLE Patients[J]. Clin Rev Allergy Immunol 44(1):23–30CrossRef
8.
go back to reference Yeager J (2018) Disseminated infection to immune activation[J]. Proc (Baylor Univ Med Cent) 31(3):345–346CrossRef Yeager J (2018) Disseminated infection to immune activation[J]. Proc (Baylor Univ Med Cent) 31(3):345–346CrossRef
10.
go back to reference Yamashita S, Furukawa NE, Matsunaga T, Hirakawa Y, Tago M, Yamashita SI (2017) Extremely high serum ferritin: an instrumental marker of masquerading adult-onset Still’s disease with hemophagocytic syndrome[J]. Am J Case Rep 18:1296–1301CrossRef Yamashita S, Furukawa NE, Matsunaga T, Hirakawa Y, Tago M, Yamashita SI (2017) Extremely high serum ferritin: an instrumental marker of masquerading adult-onset Still’s disease with hemophagocytic syndrome[J]. Am J Case Rep 18:1296–1301CrossRef
11.
go back to reference Kirino Y, Kawaguchi Y, Tada Y et al (2018) Beneficial use of serum ferritin and heme oxygenase-1 as biomarkers in adult-onset Still’s disease: a multicenter retrospective study[J]. Mod Rheumatol 28(5):858–864CrossRef Kirino Y, Kawaguchi Y, Tada Y et al (2018) Beneficial use of serum ferritin and heme oxygenase-1 as biomarkers in adult-onset Still’s disease: a multicenter retrospective study[J]. Mod Rheumatol 28(5):858–864CrossRef
12.
go back to reference Giacomelli R, Ruscitti P (2018) A comprehensive review on adult onset Still's disease[J]. J Autoimmun 93:24–36CrossRef Giacomelli R, Ruscitti P (2018) A comprehensive review on adult onset Still's disease[J]. J Autoimmun 93:24–36CrossRef
13.
go back to reference Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [J]. Arthritis Rheum 40(9):1725CrossRef Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [J]. Arthritis Rheum 40(9):1725CrossRef
14.
go back to reference Enghard P, Rieder C, Kopetschke K et al (2014) Urinary CD4 T cells identify SLE patients with proliferative lupus nephritis and can be used to monitor treatment response[J]. Ann Rheum Dis 73(1):277–283CrossRef Enghard P, Rieder C, Kopetschke K et al (2014) Urinary CD4 T cells identify SLE patients with proliferative lupus nephritis and can be used to monitor treatment response[J]. Ann Rheum Dis 73(1):277–283CrossRef
15.
go back to reference Bajema IM, Wilhelmus S, Alpers CE et al (2018) Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices[J]. Kidney Int 93(4):789–796CrossRef Bajema IM, Wilhelmus S, Alpers CE et al (2018) Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices[J]. Kidney Int 93(4):789–796CrossRef
16.
go back to reference Pradhan V, Pandit P, Rajadhyaksha A et al (2016) Association of serum ferritin levels with hematological manifestations in systemic lupus erythematosus patients from Western India[J]. J Assoc Physicians India 64(5):14–18PubMed Pradhan V, Pandit P, Rajadhyaksha A et al (2016) Association of serum ferritin levels with hematological manifestations in systemic lupus erythematosus patients from Western India[J]. J Assoc Physicians India 64(5):14–18PubMed
17.
go back to reference Seyhan S, Pamuk ÖN, Pamuk GE (2014) The correlation between ferritin level and acute phase parameters in rheumatoid arthritis and systemic lupus erythematosus[J]. Eur J Rheumatol 1(3):92–95CrossRef Seyhan S, Pamuk ÖN, Pamuk GE (2014) The correlation between ferritin level and acute phase parameters in rheumatoid arthritis and systemic lupus erythematosus[J]. Eur J Rheumatol 1(3):92–95CrossRef
18.
go back to reference Lozovoy MA, Simão AN, Oliveira SR et al (2013) Relationship between iron metabolism, oxidative stress, and insulin resistance in Patients with systemic lupus erythematosus[J]. Scand J Rheumatol 42(4):303–310CrossRef Lozovoy MA, Simão AN, Oliveira SR et al (2013) Relationship between iron metabolism, oxidative stress, and insulin resistance in Patients with systemic lupus erythematosus[J]. Scand J Rheumatol 42(4):303–310CrossRef
19.
go back to reference Wu T, Ding H, Han J et al (2016) Antibody-array-based proteomic screening of serum markers in systemic lupus erythematosus: a discovery study[J]. J Proteome Res 15(7):2102–2114CrossRef Wu T, Ding H, Han J et al (2016) Antibody-array-based proteomic screening of serum markers in systemic lupus erythematosus: a discovery study[J]. J Proteome Res 15(7):2102–2114CrossRef
20.
go back to reference Tripathy R, Panda AK (2015) Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE [J]. Lupus 24(1):82–89CrossRef Tripathy R, Panda AK (2015) Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE [J]. Lupus 24(1):82–89CrossRef
21.
go back to reference Mok CC, Ding HH, Kharboutli M et al (2016) Ferritin, insulin-like growth factor binding protein 2, and tumor necrosis factor receptor type II as biomarkers in systemic lupus erythematosus [J]. Arthritis Care Res 68(9):1303–1309CrossRef Mok CC, Ding HH, Kharboutli M et al (2016) Ferritin, insulin-like growth factor binding protein 2, and tumor necrosis factor receptor type II as biomarkers in systemic lupus erythematosus [J]. Arthritis Care Res 68(9):1303–1309CrossRef
22.
go back to reference Smith EM, Jorgensen AL, Midgley A et al (2017) International validation of a urinary biomarker panel for identification of active lupus nephritis in children[J]. Pediatr Nephrol 32(2):283–295CrossRef Smith EM, Jorgensen AL, Midgley A et al (2017) International validation of a urinary biomarker panel for identification of active lupus nephritis in children[J]. Pediatr Nephrol 32(2):283–295CrossRef
23.
go back to reference van Raaij S, van Swelm R, Bouman K et al (2018) Tubular iron deposition and iron handling proteins in human healthy kidney and chronic kidney disease[J]. Sci Rep 8(1):9353CrossRef van Raaij S, van Swelm R, Bouman K et al (2018) Tubular iron deposition and iron handling proteins in human healthy kidney and chronic kidney disease[J]. Sci Rep 8(1):9353CrossRef
24.
go back to reference Wang Y, Li MH, Zhang Y et al (2019) [Relationship between podocyte injury and macrophage infiltration in renal tissues of patients with lupus nephritis] [J]. Beijing Da Xue Xue Bao Yi Xue Ban 51(4):723–727PubMed Wang Y, Li MH, Zhang Y et al (2019) [Relationship between podocyte injury and macrophage infiltration in renal tissues of patients with lupus nephritis] [J]. Beijing Da Xue Xue Bao Yi Xue Ban 51(4):723–727PubMed
25.
go back to reference Kitagawa A, Tsuboi N, Yokoe Y et al (2019) Urinary levels of the leukocyte surface molecule CD11b associate with glomerular inflammation in lupus nephritis[J]. Kidney Int 95(3):680–692CrossRef Kitagawa A, Tsuboi N, Yokoe Y et al (2019) Urinary levels of the leukocyte surface molecule CD11b associate with glomerular inflammation in lupus nephritis[J]. Kidney Int 95(3):680–692CrossRef
Metadata
Title
Urinary ferritin creatinine ratio, a potential biomarker for lupus nephritis activity
Authors
Lin Qi
Jingyi Xu
Chunshu Yang
Xiaoyu Hou
Pingting Yang
Publication date
01-01-2021
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 1/2021
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05214-0

Other articles of this Issue 1/2021

Clinical Rheumatology 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.